OslaDex solution for infusion

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

hydroxyethyl starch

Available from:

Liqvor CJSC

ATC code:

B05AA07

INN (International Name):

hydroxyethyl starch

Dosage:

60mg/ml

Pharmaceutical form:

solution for infusion

Units in package:

100ml plastic pack, 200ml plastic pack, 500ml plastic pack

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-08-08

Summary of Product characteristics

                                CYMl.\f,
APHA.fl
X APA KTEPIICTHITA JIE
K
AP C
TB
A}IHO
T
O
C
P
EACT
B
A
Ocnafietcerm
1.
Konnuep.lsexoe
Hflr.lmelroBilHu,€
HpenapaT*
:
tr-I
eixgyn sp
oAHCIe
renarenToo
a
HHo€
Ir a3B
a
rI H
e
:
2.
Konutfiscrgsfrn:bni
u
Kilrlecrgennnrff
cocran"
f ngp orccHDTHx
ICp
axM
aJI
(crenesb
3aMeIrIeHI,Ifl
0,45-0,5
5
;
cpelsnff
ldorlelqynxpuufi
nec
2000
00)
Harplu
KJIopI.{A
Boxa,qJIf
lIHteKuHfi
Ocna,.{e$crV
I
rapp
o
tccua
TI4
JI
Kp
axM
att
-
60,0
rln
-
9,0
r/n
Oapua,ue*TutrecRafl
rfuopma:
pacrnop
gnx
uH$ysHH
6
%
4"
K.unnnrr**.',gs,
xapaKTgpl,fcrl{:rttrr
4,
1,.
ffo,rcilsfiLrufl
K npumelreg'n*o
flpo$ranaKTuxa
H
Jler{exae
THIIoB:oneMHI'I'
4.2,
Pe,iKIrM
AoSnponarrnff
f{penapar
BBoAlrT
nyreM
u/e
nHSysHH.
V.;grrrsaf;,
BosMoffiH6le
aua,SunaKTotrgnrle
peaKrII.{}I}
nepnrte
10-20
httl
ilpenapara
cneAyer
BBo.ilnrb
MeAJIBT{Ho,
no,[ Tlrlarer{bnblM
ua6lroAgnnehI
3a
cocroflHl{elt
naur4cHTa.
Cyroxxax
.{ffia
H
cgopocT6
gu$ysum
}r0TasagfiI4tsa}orc*
HHAHBI{AyatlbFto,
B
t
-
.
3ag,r{el{-,b{oc
{
oT
0renenl/i
KFOBOII0T0FH,
FbIpAx{e}rHCIGT}I
I{epyu€}II4I'I
reu
oAIdI.mMprNn
n noxagaten*
FEIvI
SToxpHTa.
llpenapar
oJreAy*er
nplanneHrrb
B
rlyIlIHI,rMaJI
r-r6rx rtp$erctrBlrblx
&o3ax
B
TsqeHlle
xparuafimero
nepr{oga
Bpeti{enrir,
roil
HenpepbIBI{bIM
na6lrcAeI'I}IeM
3a
reMoAHHaMI,IKofi.
y
uon,ogbrK
narlgerrTos
6es
pncxe
rropalKer{r4n
cepfigrl]IQ-cocyAHgrofi
cncrel\'Ibl
I{
JrerKI{x
qFerefioM
nprirMeuennfi
l{oJlno}tAldoro
odtentga*rsularcuero
fipenapara
CrrrrtaeT,cr{
reMaroKpI,IT
p:auubtff
3gUU
H M6fies.
o6H.rHO,
oyToqgAfi
AOsA
cocTaBnser
500
-
1000
run'
Maxc*laaJlbHas
cyror{Har
,[o3a
He
Aorr]KHa
npeBrtuarr
20
rnr"rr/rr
]\raccbr
reJla
B
gsr{b
(r/p
nns
rrauHeHTa
e Becobr
?5
xr
sr&KCrrMaJrEHa-$
cyroqHa{. ilosa
cocraBJlfler
1500
M r { ) .
Y
espocirbrx
cK0pocTr
nH$yr
wI|
He
AOJIIKHa
rpeBbllllarr
20
Ntn/xr/'I'
Y
lereft
B Bo3pacre
Ao
10 ner
cKopocrs
nHSy:'HH
He
'IOJIXI{a
npeBblilraTb
15
Mn/rr
/'I.
llpogonl1rrroJtblrocrb
rrerreHu.tl
gaBpIcHT
or
npogo.nlKllTeJlbHocrH
vr
T'flxecru
rHnoBoJIeI!{HH!reI{oAI{I{aI\,{HKHHTSM0AHIIoEH!{.
4.3.
fIpornnon
orca3aH
Ir
f l
-
i
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Russian 11-03-2019